Bicara TherapeuticsBCAX
那斯達克 · USD
20.21
-0.35
(-1.70%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Bicara TherapeuticsBCAX
20.21
-0.35
(-1.70%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 60,242 | 41,122 | 40,676 | 32,018 | - | - | 20,628 | 19,750 | 15,374 | 13,687 |
研發費用 | 47,500 | 32,990 | 32,975 | 24,798 | 34,333 | 19,883 | 15,863 | 15,841 | 12,032 | 10,562 |
推銷及管理費用 | 12,742 | 8,132 | 7,701 | 7,220 | 7,455 | 6,754 | 4,765 | 3,909 | 3,342 | 3,125 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -60,242 | -41,122 | -40,676 | -32,018 | -41,788 | -26,637 | -20,628 | -19,750 | -15,374 | -13,687 |
其他收入及費用 | 4,083 | 3,789 | 4,386 | 4,682 | 5,014 | 5,866 | 3,147 | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -56,159 | -37,333 | -36,290 | -27,336 | -36,774 | -20,771 | -17,481 | -17,049 | -12,507 | -12,435 |
所得稅 | 52 | 53 | 40 | 52 | 72 | 186 | - | - | 1 | 5 |
稅後純益 | -56,211 | -37,386 | -36,330 | -27,388 | -36,846 | -20,957 | -17,481 | -17,049 | -12,508 | -12,440 |
基本每股稅後盈餘(元) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.39 | -1.60 | -0.33 | -0.24 | - |
稀釋每股稅後盈餘(元) | -0.93 | -0.68 | -0.66 | -0.50 | -0.68 | 7.22 | 26.92 | -0.33 | -0.24 | - |
基本平均股數(千股) | 60717.00 | 55142.00 | 54563.00 | 54539.00 | 54456.00 | 54424.00 | 10901.00 | 51760.00 | 51760.00 | - |
稀釋平均股數(千股) | 60717.00 | 55142.00 | 54563.00 | 54539.00 | 54456.00 | 54424.00 | 10901.00 | 51760.00 | 51760.00 | - |
還原基本每股稅後盈餘(元) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.39 | -1.60 | -0.33 | -0.24 | - |
還原稀釋每股稅後盈餘(元) | -0.93 | -0.68 | -0.66 | -0.50 | -0.68 | 7.22 | 26.92 | -0.33 | -0.24 | - |
還原基本平均股數(千股) | 60,717 | 55,142 | 54,563 | 54,539 | 54,456 | 54,424 | 10,901 | 51,760 | 51,760 | - |
還原稀釋平均股數(千股) | 60,717 | 55,142 | 54,563 | 54,539 | 54,456 | 54,424 | 10,901 | 51,760 | 51,760 | - |
EBITDA(千元) | -55,777 | -37,021 | -36,234 | -27,317 | -36,755 | -20,756 | -17,466 | -17,036 | -12,494 | -12,421 |